Hubungan Kadar High Density Lipoprotein Dengan Derajat Keparahan Dari Penyakit Jantung Koroner

Rosa Zorayatamin Damanik


Abstract


Penyakit jantung coroner (PJK) merupakan salah satu penyebab kematian terbanyak di Indonesia bahkan didunia.derajat sumbatan PJK dapat dinilai dari aingiography.kadar High Density Lipoprotein (HDL) dilaporkan dapat mencegah perkembangan atherosclerosis pada PJK. Tujuan dari penelitian ini ialah untuk mengetahui hubungan kadar HDL dihubungkan dengan derajat keparahan dari penyakit jantung koroner menggunakan skor gensini serta penelitian ini menggunakan metode obeservasional dengan pendekatan cross sectional. Penelitian ini menggunakan 48 sampel pasien yang didiagnosis penyakit jantung coroner kemudian diperiksa kadar serum HDL dalam darah pasien serta dilakukan pemeriksaan coronary angiography kemudian derajat keparahan dari stenosis arteri coroner dinilai dengan menggunakan skor gensini. Pada hasil penelitian didapatkan rerata dari kadar HDl sebesar 41,6 (SD±16.85), kemudian dilakukan uji korelasi spearman dan didapatkan nilai P=0,002 (r=-0,427) sehingga terdapat hubungan antara kadar HDL dengan derajat keparahan pada penyakit jantung coroner

Keywords


Penyakit Jantung Koroner, HDL, Gensini Score

Full Text:

PDF

References


Ahmed, M. I. et al. (2018) ‘Relationship between HDL-Cholesterol and Angiographic Severity of Coronary Artery Disease’, Bangladesh Heart Journal, 33(1), pp. 32–38. doi: 10.3329/bhj.v33i1.37023.

Annema, W. and von Eckardstein, A. (2013) ‘High-Density Lipoproteins’, Circulation Journal, 77(10), pp. 2432–2448. doi: 10.1253/circj.CJ-13-1025.

Avci, E. et al. (2018) ‘Relationship between high-density lipoprotein cholesterol and the red cell distribution width in patients with coronary artery disease’, Lipids in Health and Disease. Lipids in Health and Disease, 17(1), pp. 4–9. doi: 10.1186/s12944-018-0709-5.

Bhatia, S. K. (2010) ‘Coronary Artery Disease’, Biomaterials for Clinical Applications, 1(1), pp. 23–49. doi: 10.1007/978-1-4419-6920-0.

Eren, E., Yilmaz, N. and Aydin, O. (2012) ‘High Density Lipoprotein and it’s Dysfunction’, The Open Biochemistry Journal, 6(1), pp. 78–93. doi: 10.2174/1874091x01206010078.

Fisher, E. A. et al. (2012) ‘High-density lipoprotein function, dysfunction, and reverse cholesterol transport’, Arteriosclerosis, Thrombosis, and Vascular Biology, 32(12), pp. 2813–2820. doi: 10.1161/ATVBAHA.112.300133.

Gordon, S. M. et al. (2011) ‘High density lipoprotein: It’s not just about lipid transport anymore’, Trends in Endocrinology and Metabolism. Elsevier Ltd, 22(1), pp. 9–15. doi: 10.1016/j.tem.2010.10.001.

Kadi, H. et al. (2012) ‘The Relationship Between High-Density Lipoprotein Cholesterol and Coronary Collateral Circulation in Patients With Coronary Artery Disease’, Journal of Investigative Medicine, 60(5), pp. 808–813. doi: 10.231/JIM.0b013e31824e980c.

Kosmas, C. E. et al. (2018) ‘High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease’, Drugs in Context, 7, pp. 1–9. doi: 10.7573/dic.212525.

Lashmanados, U. (2010) ‘Overview of Coronary Artery Disease’, Intechopan.com, 1(1), pp. 3–14.

Libby, P. and Theroux, P. (2005) ‘Pathophysiology of Coronary Artery Disease. Circulation’, Circulation Journal, 111, pp. 3481–3488.

Libby, P. et al. (2014) ‘Pathophysiology of Coronary Artery Disease’, American Heart Journal, 1(1), pp. 1–9. doi: 10.1161/CIRCULATIONAHA.105.537878.

Murphy, A. J. et al. (2008) ‘High-density lipoprotein reduces the human monocyte inflammatory response’, Arteriosclerosis, Thrombosis, and Vascular Biology, 28(11), pp. 2071–2077. doi: 10.1161/ATVBAHA.108.168690.

Park, S. H. et al. (2003) ‘Involvement of transcription factors in plasma HDL protection against TNF-α-induced vascular cell adhesion molecule-1 expression’, International Journal of Biochemistry and Cell Biology, 35(2), pp. 168–182. doi: 10.1016/S1357-2725(02)00173-5.

Patel, K. V. et al. (2009) ‘Red blood cell distribution width and the risk of death in middle-aged and older adults’, Archives of Internal Medicine, 169(5), pp. 515–523. doi: 10.1001/archinternmed.2009.11.

Rader, D. J. and Kees Hovingh, G. (2014) ‘HDL and cardiovascular disease’, The Lancet. Elsevier Ltd, 384(9943), pp. 618–625. doi: 10.1016/S0140-6736(14)61217-4.

Skjelbakken, T. et al. (2014) ‘Red cell distribution width is associated with incident myocardial infarction in a general population: The tromsø study’, Journal of the American Heart Association, 3(4), pp. 1–10. doi: 10.1161/JAHA.114.001109.

Subedi, B. H. et al. (2014) ‘Current guidelines for high-density lipoprotein cholesterol in therapy and future directions.’, Vascular health and risk management, 10, pp. 205–216.

Tolle, M. et al. (2008) ‘HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production’, Arteriosclerosis, Thrombosis, and Vascular Biology, 28(8), pp. 1542–1548. doi: 10.1161/ATVBAHA.107.161042.

Toth, P. P. et al. (2013) ‘High-density lipoproteins: A consensus statement from the National Lipid Association’, Journal of Clinical Lipidology. Mosby, Inc, 7(5), pp. 484–525. doi: 10.1016/j.jacl.2013.08.001.

Zheng, C. and Aikawa, M. (2012) ‘High density lipoprotein.’, Journal of the American College of Cardiology. Elsevier Inc., 60(23), pp. 269–271. doi: 10.1016/j.jacc.2012.08.999.




DOI: https://doi.org/10.30743/best.v5i2.9233

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.